Bookmark and Share

Compound Summary for: CID 5733

zomepirac

Also known as: ZOMEPIRAC SODIUM; Zomepiracum; Zomepiracum [INN-Latin]; Zomax; 5-(4-Chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetic acid; 33369-31-2
Molecular Formula: C15H14ClNO3   Molecular Weight: 291.72956   InChIKey: ZXVNMYWKKDOREA-UHFFFAOYSA-N
Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions. The manufacturer voluntarily removed Zomax tablets from the Canadian, US, and UK markets in March 1983.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _